Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term cell-lines. Found 41 abstracts

no pagination
Kadariya Y, Tang BQ, Myers CB, Fukui J, Peterson JR, Kruger WD. Chemical Genetic Screening for Compounds That Preferentially Inhibit Growth of Methylthioadenosine Phosphorylase (MTAP)-Deficient Saccharomyces cerevisiae. Journal of Biomolecular Screening. 2011 Jan;16(1):44-52.   PMCID: PMC3019245
Choi YL, Bocanegra M, Kwon MJ, Shin YK, Nam SJ, Yang JH, Kao J, Godwin AK, Pollack JR. LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer. Cancer Research. 2010 Mar;70(6):2296-306.   PMCID: PMCID: PMC2869247 [Available on 2011/3/15]
Ibragimova I, de Caceres, Hoffman AM, Potapova A, Dulaimi E, Al-Saleem T, Hudes GR, Ochs MF, Cairns P. Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer. Cancer Prevention Research. 2010 Sep;3(9):1084-92.   PMCID: PMC2933318
Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR. A mouse model recapitulating molecular features of human mesothelioma. Cancer Research. 2005 Sep 15;65(18):8090-5.
Arias-Mendoza F, Zakian K, Schwartz A, Howe FA, Koutcher JA, Leach MO, Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, Charles HC, Brown TR. Methodological standardization for a multi-institutional in vivo trial of localized P-31 MR spectroscopy in human cancer research. In vitro and normal volunteer studies. Nmr in Biomedicine. 2004 Oct;17(6):382-91.
Finegan MM, Han AC, Edelson MI, Rosenblum NG. p16 expression in squamous lesions of the female genital tract. Journal of Molecular Histology. 2004 Feb;35(2):111-4.
Guo JT, Sohn JA, Zhu Q, Seeger C. Mechanism of the interferon alpha response against hepatitis C virus replicons. Virology. 2004 Jul;325(1):71-81.
Miknyoczki SJ, Chang H, Klein-Szanto A, Dionne CA, Ruggeri BA. The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma. Clinical Cancer Research. 1999 Aug;5(8):2205-12.
Miknyoczki SJ, Dionne CA, Klein-Szanto AJ, Ruggeri BA. The novel Trk receptor tyrosine-kinase inhibitor CEP-701 (KT- 5555) exhibits antitumor efficacy against human pancreatic carcinoma (Panc1) xenograft growth and in vivo invasiveness. In: Cell and Molecular Biology of Pancreatic Carcinoma: Recent Developments in Research and Experimental Therapy. 1999. p. 252-62.
Ozols R. Treatment of gynecologic cancer: The US experience. Tumori. 1999 May;85(3):S5-S11.
Pass HI, Robinson BW, Testa JR, Carbone M. Emerging translational therapies for mesothelioma. Chest. 1999 Dec;116(6):455S-460S.
Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology. 1999 Jul;54(1):178-82.
Ma JG, Fei ZL, Klein-Szanto A, Gallo JM. Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor. Clinical & Experimental Metastasis. 1998 Aug;16(6):559-68.
Morgan AS, Sanderson PE, Borch RF, Tew KD, Niitsu Y, Takayama T, Von Hoff DD, Izbicka E, Mangold G, Paul C, Broberg U, Mannervik B, Henner WD, Kauvar LM. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase. Cancer Research. 1998 Jun 15;58(12):2568-75.
Orlow SJ, Silvers WK, Zhou BK, Mintz B. Comparative decreases in tyrosinase, TRP-1, TRP-2, and Pmel 17/silver antigenic proteins from melanotic to amelanotic stages of syngeneic mouse cutaneous melanomas and metastases. Cancer Research. 1998 Apr;58(7):1521-3.
Wu TT, Su YH, Block TM, Taylor JM. Atypical splicing of the latency-associated transcripts of herpes simplex type 1. Virology. 1998 Mar 30;243(1):140-9.
Rondinelli RH, Epner DE, Tricoli JV. Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer and Prostatic Diseases. 1997 Dec;1(2):66-72.
Ruggeri BA, Huang LY, Berger D, Chang H, KleinSzanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Molecular pathology of primary and metastatic ductal pancreatic lesions - Analyses of mutations and expression of the p53, mdm- 2, and p21/WAF-1 genes in sporadic and familial lesions. Cancer. 1997 Feb 15;79(4):700-16.
Smith MK, Goral MA, Wright JH, Matrisian LM, Morris RJ, KleinSzanto AJ, Gilmour SK. Ornithine decarboxylase overexpression leads to increased epithelial tumor invasiveness. Cancer Research. 1997 Jun;57(11):2104-8.
Ciaccio PJ, Tew KD. Adaptive response to glutathione S-transferase inhibitors. British Journal of Cancer. 1996 Jul;74:S93-S98.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term cell-lines

cell-lines cancer expression carcinoma chemotherapy induction p53 gene in-vitro ethacrynic-acid adenocarcinoma receptor metastasis drug- factor-i enhanced expression radiation-therapy alkylating-agents protein resistance resistant gstp1 hypermethylation cytolytic t-lymphocytes mice gapdh hepatitis-delta virus activation gamma- asbestos-induced mesotheliomas mtap genes dna-repair ras oncogene yeast localized P-31 MR spectroscopy hepatitis C virus IFN-alpha-RNA amplification malignant mesothelioma dna methylation large-t-antigen specificity mutations mdm2-deficient mice nf2 progression genes analysis magnetic-resonance spectroscopy kunjin virus entry site fibroblast growth-factors double-stranded-rna multi-institutional trial single strand conformation polymorphism northern and RNA cyto-toxicity factor receptor brain-tumors human ovarian-cancer Factor VIII potential application apoptosis united-states tumorigenesis human cancer research tumor-suppressor gene common non-invasive papillomas immunotherapy homozygous deletions leukemia mdm9 kinase VEGF WAF-1 nude-mice mass- susceptibility pancreatic adenocarcinoma metabolic characterization stromelysin-1 ethacrynic acid translation hypoxia ornithine-decarboxylase tumor angiogenesis gamma-interferon DT-diaphorase cdkn2 model leukemic-cells pleural mesothelioma BSO lung-carcinoma p16(ink4a) epidermal tumors clinicopathological features hla-a2 gst-pi-gene phase-i neurofibromatosis-2 buthionine sulfoximine dose intensity identification T199 aberrant promoter methylation heat-shock protein prostate-cancer spectrometry codeletion mouse skin transformation glioma xenograft tissues cigarette-smoking GAPDH men src family kinases dna-sequences immunohistochemistry gp100 inhibits growth nitrogen mustard- gene-therapy insulin-like-growth-factor-1 sensitivity growth-factor receptor chlorambucil drug screening methionine salvage pathway-yeast-genetic-chemical interaction tyrosine nad(p)h-quinone oxidoreductase gene glutamylcysteine synthetase white human-malignant mesothelioma african-american dl-alpha-difluoromethylornithine melanomas intron growth- embryonic lethality human brain tumor progression lat histone deacetylase inhibition methodological standardization pre-messenger-rna prostate neoplasia permeability factor inhibition discovery
Last updated on Friday, January 03, 2020